Screener
Supernus Pharmaceuticals SUPN Business Segments — Internal employee-related expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Supernus Pharmaceuticals in its filing.
Tagged under the XBRL concept supn:InternalResearchAndDevelopmentExpense.
The source filing: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001356576-26-000022
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Qelbree | 2,364 | 4,413 |
| ZURZUVAE | 82 | — |
| Early-stage programs and other expenses | 6,565 | 3,213 |
| Total external development program expenses | 27,678 | 16,432 |
| Internal employee-related expenses | 11,760 | 10,495 |
| Total research and development expenses | 39,438 | 26,927 |
| Other segment items(a) | 21,996 | 29,017 |
| Net loss | $(2,293) | $(11,827) |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is Supernus Pharmaceuticals's business segments — internal employee-related expenses?
- Supernus Pharmaceuticals (SUPN) reported business segments — internal employee-related expenses of $11.76M in Q1 2026.
- How has Supernus Pharmaceuticals's business segments — internal employee-related expenses changed year-over-year?
- Supernus Pharmaceuticals's business segments — internal employee-related expenses increased by 12.1% year-over-year, from $10.5M to $11.76M.
- What is the long-term trend for Supernus Pharmaceuticals's business segments — internal employee-related expenses?
- Over 3 years (2022 to 2025), Supernus Pharmaceuticals's business segments — internal employee-related expenses has grown at a 11.8% compound annual growth rate (CAGR), from $31.56M to $44.07M.
- What does business segments — internal employee-related expenses mean?
- Includes compensation, benefits, and related costs for personnel directly involved in the segment's operations. This reflects the human capital investment required to support the company's ongoing commercial and development activities.
Ask your AI about Supernus Pharmaceuticals's business segments — internal employee-related expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude